The treatment paradigm ... with clinically localized prostate cancer. Pathologic assessment paid particular attention to laterality and PTI, along with pathologic Gleason score.

Background: In this population-based study, we investigated the degree of concordance between Gleason scores obtained ... for this study all 371 prostate cancer patients recorded at the Geneva ...

ADT: Androgen Deprivation Therapy, or ADT, is a term used to describe the most common hormone therapy for patients with prostate cancer, treatments that reduce androgen production by the testicles.

Using data from the population-based Geneva Cancer Registry, we considered for this study all 371 prostate cancer patients ... lymph node status; treatment; survival status; and cause of death.

Medically reviewed by Amelia MacIntyre, DO Approximately 1 in 8 people with a prostate are diagnosed with prostate cancer ...

The American Cancer Society estimates that 288,300 new cases of prostate cancer will be diagnosed in 2023. While the overall ...

The MMAI risk classification identified 43.5% of patients as low-risk, 34.6% as intermediate-risk, and 21.8 ... Gleason Score, Gleason primary, and secondary patterns, and T-stage) of patients from ...